Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: A five-year cohort study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 928-933

  Wong, Martin C S ^a   Tam, Wilson W S ^a,d   Cheung, Clement S K ^b   Wang, Harry H X ^a   Tong, Ellen L H ^b   Sek, Antonio C H ^b   Yan, Bryan P Y ^a   Cheung, N T ^c   Leeder, Stephen ^c   Yu, C M ^a   Griffiths, Sian ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adherence; Antihypertensive agents; Associated factors; Cardiovascular mortality

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; HONG KONG; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADHERENCE; ANTIHYPERTENSIVE AGENTS; ASSOCIATED FACTORS; CARDIOVASCULAR MORTALITY;

AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; STROKE;

EID: 84885305669     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.048     Document Type: Article

References (45)

1. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education ProgramCoordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-72.
2. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.
3. Sabate E. Evidence for action. Geneva: World Health Organization; 2003.
4. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-7.
5. van Wijk BL, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens 2008;26:145-53.
6. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999;160:31-7.
7. Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005;19:607-13.
8. Hughes DA, Bagust A, Haycox A, Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 2001;10:601-15.
9. Mar J, Rodríguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J Hypertens 2001;19:149-55.
10. Mancia G, De Backer G, Dominiczak A, et al. The ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25:1751-62.
11. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30.
12. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-605.
13. Chobanian AV. Impact of nonadherence to antihypertensive therapy. Circulation 2009;120:1558-60.
14. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290: 199-206.
15. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113: 203-12.
16. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Int Med 2006;166:1836-41.
17. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008;155:772-9.
18. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86.
19. Wong MCS, Jiang Y, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008;8:138.
20. Wong MCS, Jiang JY, Griffiths SM. Factors associated with compliance to thiazide diuretics among 8551 Chinese patients. J Clin Pharm Ther 2011;36: 179-86.
21. Wong MCS, Jiang JY, Griffiths SM. Adherence to combination therapy among ethnic Chinese patients: a cohort study. Hypertens Res 2010;33:416-21.
22. Wong MCS, Jiang JY, Griffiths SM. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Clin Ther 2009;31:2170-7.
23. Wong MCS, Jiang JY, Griffiths SM. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol 2010;50:598-605.
24. Wong MCS, Jiang JY, Griffiths SM. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens 2009;22:904-10.
25. Wong MCS, Tam WWS, Cheung CSK, et al. Medication adherence to first-line antihypertensive drug class in a large Chinese population. Int J Cardiol 2013;167:1438-42.
26. Sun W, Schooling M, Chan WM, Ho KS, Lam TH. The association between depressive symptoms and mortality among Chinese elderly: a Hong Kong cohort study. J Gerontol A Biol Sci Med Sci 2011;66A:459-66.
27. Schooling CM, Lam TH, Li ZB, et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006;166: 1498-504.
28. Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: case-control study of all adult deaths in. BMJ 1998;2001:323-61.
29. Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009;15:457-64.
30. Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with sampling drug use, medication switching and therapeutic duplication. Ann Pharmacother 2009;43:36-44.
31. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74.
32. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007;45:S103-7.
33. D'Agostino RB. Propensity scores in cardiovascular research. Circulation 2007;115: 2340-3.
34. Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011;29:610-8.
35. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008;24:121-7.
36. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006;185:487-9.
37. Kettani FZ, Dragomir A, Côté R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009;40:213-20.
38. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 2009;266:207-18.
39. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol 2010;69: 74-84.
40. Dragomir A, Cô,té R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010;48: 418-25.
41. Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008;118:2679-86.
42. Ma WJ, Tang JL, Zhang YH, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens 2012;25:590-6.
43. Hsu YH, Mao CL, Wey M. Antihypertensive medication adherence among elderly Chinese Americans. J Transcult Nurs 2010;21:287-305.
44. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 1996;144:934-42.
45. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296:2563-71.